Johnson & Johnson

NYSE: JNJ
$149.43
+$2.38 (+1.6%)
Closing Price on July 10, 2024

JNJ Chart and Intraday Price

JNJ Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 390,509.79M USD
Shares Outstanding 2,408,770,000
Johnson & Johnson is a global healthcare giant founded in 1886, headquartered in New Brunswick, New Jersey. It operates in the healthcare sector, offering a wide range of products across various therapeutic areas including immunology, infectious diseases, neuroscience, oncology, cardiovascular, and metabolism. Additionally, it has a MedTech segment that provides interventional solutions, orthopaedics, surgery technologies, contact lenses, and intraocular lenses. The company's products are distributed worldwide to retailers, wholesalers, hospitals, and healthcare professionals, emphasizing its commitment to improving health for people everywhere.

JNJ Articles

24/7 Insights Despite the huge run in the Nasdaq and S&P 500 this year, dividend stocks are still reasonable. Blue chip dividend stocks will run when rates start to come down. Grab this free...
24/7 Wall Street Insights With inflation showing few signs of appreciable reversal, prices for other goods and services will inevitably continue to rise. Among the passive income options available to...
ETFs have become an exceptionally popular choice for investors seeking diversification and exposure to large market segments. Thematic ETFs, like the iShares S&P 500 Value ETF (NYSE: IVE),...
While getting to retirement age can be a blessing and a curse, the reality of counting on the U.S. government to provide for your needs is not the best idea. The full retirement age is 66 if you were...
24/7 Insights Passive income is an easy way to supplement retirement and pension distributions. The Dividend Aristocrats are a solid play now for worried investors. Access 2 legendary, high-yield...
24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts’ forecasts and prospered accordingly. In 5 Years, Eli Lilly has...
The U.S. economy is primarily driven by consumer spending. To put it another way, the country’s economy depends, to a large extent, on the private sector’s ability to identify — and sell —...
Investors are drawn to dividend stocks for their reliable income and the potential for a robust total return. Total return encompasses interest, capital gains, dividends, and distributions...
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
On the cover of the Friday, April 12, 2024 edition of The Wall Street Journal, the headline read: “Cost of Owning a Home Soars”. The article cited one family whose home insurance costs had risen...
After years of a low-interest rate environment, which has reversed significantly over the last two years, many investors continue to turn to equities for growth potential and solid and dependable...
In today’s episode of the 24/7 finance series analyst Jeremy Phillips and Austin Smith discuss rebounding inflation, and two stocks for investors to look at today. In inflationary times many...
Over the last two years, interest rates have jumped from historical lows of literally 0% to the highest level since 2007 at 5.5%. 30 FHA Mortgages have jumped from 2.65% in January of 2021 to the...
The aging population and increasing life expectancy of Baby Boomers have created a growing demand for investments that provide reliable income and the potential for long-term growth. High-yield...
In the high-stakes world of investing, the late great Charlie Munger’s playbook stands out for its focus on fundamental strength and long-term value—principles that have cemented his legacy...